DCISionRT Enhances DCIS Risk Stratification Beyond Clincopathology
Written by
Cancer Network
Published
0
comments
0
min
Patients reclassified to high-risk clinicopathology with DCISionRT saw an absolute reduction in IBR rates of 11.6%; from 17.7% to 6.1%.